Research Center: University Hospitals Cleveland Medical Center
Location: 11100 Euclid Ave, Bolwell 3100, Cleveland, OH 44106
Lead Researcher: Neil Korman
IRB: This study has been reviewed and approved by the University Hospitals Cleveland IRB

Psoriasis is a chronic condition affecting millions, causing uncomfortable and visible skin patches. While treatments are available, many individuals still struggle to find lasting relief. This study is exploring the potential benefits of the Mediterranean diet in improving psoriasis symptoms.

With its focus on anti-inflammatory foods, including healthy fats, fruits, and vegetables, the Mediterranean diet may offer a natural way to manage psoriasis. To participate, you must have psoriasis affecting at least 5% of your body and have insurance that can cover the study drug.

Join researchers from the University Hospitals Cleveland Medical Center to see how simple dietary changes could positively impact your skin health and overall well-being.
Sign up today to take part and contribute to groundbreaking research on psoriasis treatment!

• This study may provide valuable information about how psoriasis works and may help guide a more personalized medicine approach. It is possible that some beneficial weight loss may occur as a result of participation in this study.
• Participants will be contributing valuable information that may benefit those with psoriasis in the future.
• Participants will be helping to advance medical research.

• You will receive a detailed outline of all details of the study, including treatment, risks, and procedures, and you will be given the chance to ask study staff questions before you decide whether to participate.
• If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.

Eligible:

• Men and women diagnosed with Plaque Psoriasis for at least 12 months.
• Those with psoriasis affecting at least 5% of their body.
• Must have insurance that can cover the study drug.
• Willing to refrain from prolonged sun exposure or using tanning booths.
• Must be able and willing to participate in the study for approximately 10 weeks, including attending study visits and completing various assessments (such as blood draws, optional skin or stool samples, and physical exams).

Ineligible:

• Those with other inflammatory or dermatologic conditions that would interfere with study results.
• Individuals who are currently pregnant, breastfeeding, or diagnosed with certain major health conditions, including heart disease, serious infections, or cancer, within the last year.
• Those with a history of substance abuse or major psychiatric illness requiring hospitalization in the past 3 years.
• People who are unable or unwilling to discontinue current psoriasis treatments (e.g., prescription creams, pills, or biologics) for two weeks prior to the study.

University Hospitals Cleveland Medical Center
University Hospitals Cleveland Medical Center (UH Cleveland Medical Center) is a leading academic medical center and the flagship facility of the University Hospitals health system, located in Cleveland’s University Circle. It’s a nationally ranked hospital known for its comprehensive care, research, and medical education, affiliated with Case Western Reserve University.